Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model

References

• Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8:481–90. doi:10.1038/nrmicro2337. PMID:20514045
   PubMed Web of Science ®Google Scholar
• Gil-Montoya JA, de Mello AL, Barrios R, Gonzalez-Moles MA, Bravo M. Oral health in the elderly patient and its impact on general well-being: a nonsystematic review. Clin Interv Aging. 2015;10:461–7. doi:10.2147/CIA.S54630. PMID:25709420
   PubMed Web of Science ®Google Scholar
• Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, Taylor GW, Page RC, Beck JD, Genco RJ. Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015;86:611–22. doi:10.1902/jop.2015.140520. PMID:25688694
   PubMed Web of Science ®Google Scholar
• Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000. 1997;14:216–48. doi:10.1111/j.1600-0757.1997.tb00199.x. PMID:9567973
   PubMed Web of Science ®Google Scholar
• Ng HM, Kin LX, Dashper SG, Slakeski N, Butler CA, Reynolds EC. Bacterial interactions in pathogenic subgingival plaque. Microb Pathog. 2016;94:60–9. doi:10.1016/j.micpath.2015.10.022. PMID:26541672
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27:409–19. doi:10.1111/j.2041-1014.2012.00663.x. PMID:23134607
   PubMed Web of Science ®Google Scholar
• Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15:30–44. doi:10.1038/nri3785. PMID:25534621
   PubMed Web of Science ®Google Scholar
• Meyle J, Chapple I. Molecular aspects of the pathogenesis of periodontitis. Periodontol 2000. 2015;69:7–17. doi:10.1111/prd.12104. PMID:26252398
   PubMed Web of Science ®Google Scholar
• Ng HM, Kin LX, Dashper SG, Slakeski N, Butler CA, Reynolds EC. Bacterial interactions in pathogenic subgingival plaque. Microb Pathog. 2015; PMID:26541672
   PubMed Web of Science ®Google Scholar
• Hasan A, Palmer RM. A clinical guide to periodontology: pathology of periodontal disease. Br Dent J. 2014;216:457–61. doi:10.1038/sj.bdj.2014.299. PMID:24762896
   PubMed Web of Science ®Google Scholar
• Jong RA, van der Reijden WA. Feasibility and therapeutic strategies of vaccines against Porphyromonas gingivalis. Expert Rev Vaccines. 2010;9:193–208. doi:10.1586/erv.09.156. PMID:20109029
   PubMed Web of Science ®Google Scholar
• How KY, Song KP, Chan KG. Porphyromonas gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line. Front Microbiol. 2016;7:53. doi:10.3389/fmicb.2016.00053. PMID:26903954
   PubMed Web of Science ®Google Scholar
• Grover V, Kapoor A, Malhotra R, Kaur G. Porphyromonas gingivalis antigenic determinants–potential targets for the vaccine development against periodontitis. Infect Disord Drug Targets. 2014;14:1–13. doi:10.2174/1871526514666140827100930. PMID:25159307
   PubMedGoogle Scholar
• Liu PF, Haake SK, Gallo RL, Huang CM. A novel vaccine targeting Fusobacterium nucleatum against abscesses and halitosis. Vaccine. 2009;27:1589–95. doi:10.1016/j.vaccine.2008.12.058. PMID:19162109
   PubMed Web of Science ®Google Scholar
• Reynolds EC, O'Brien-Simpson N, Rowe T, Nash A, McCluskey J, Vingadassalom D, Kleanthous H. Prospects for treatment of Porphyromonas gingivalis-mediated disease - immune-based therapy. J Oral Microbiol. 2015;7:29125. doi:10.3402/jom.v7.29125. PMID:26387645
   PubMed Web of Science ®Google Scholar
• Holmgren J, Svennerholm AM. Vaccines against mucosal infections. Curr Opin Immunol. 2012;24:343–53. doi:10.1016/j.coi.2012.03.014. PMID:22580196
   PubMed Web of Science ®Google Scholar
• Chen K, Cerutti A. Vaccination strategies to promote mucosal antibody responses. Immunity. 2010;33:479–91. doi:10.1016/j.immuni.2010.09.013. PMID:21029959
   PubMed Web of Science ®Google Scholar
• Polak D, Wilensky A, Shapira L, Weiss EI, Houri-Haddad Y. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis. J Clin Periodontol. 2010;37:812–7. doi:10.1111/j.1600-051X.2010.01598.x. PMID:20670341
   PubMed Web of Science ®Google Scholar
• Rhee JH, Lee SE, Kim SY. Mucosal vaccine adjuvants update. Clin Exp Vaccine Res. 2012;1:50–63. doi:10.7774/cevr.2012.1.1.50. PMID:23596577
   PubMedGoogle Scholar
• Lee SE, Kim SY, Jeong BC, Kim YR, Bae SJ, Ahn OS, Lee JJ, Song HC, Kim JM, Choy HE, et al. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect Immun. 2006;74:694–702. doi:10.1128/IAI.74.1.694-702.2006. PMID:16369026
   PubMed Web of Science ®Google Scholar
• Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice. Vaccine. 2011;29:5731–9. doi:10.1016/j.vaccine.2011.05.095. PMID:21696869
   PubMed Web of Science ®Google Scholar
• Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, et al. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine. 2012;30:466–74. doi:10.1016/j.vaccine.2011.10.058. PMID:22051136
   PubMed Web of Science ®Google Scholar
• Lee SE, Nguyen CT, Kim SY, Thi TN, Rhee JH. Tetanus toxin fragment C fused to flagellin makes a potent mucosal vaccine. Clin Exp Vaccine Res. 2015;4:59–67. doi:10.7774/cevr.2015.4.1.59. PMID:25649002
   PubMed Web of Science ®Google Scholar
• Lim JS, Nguyen KC, Nguyen CT, Jang IS, Han JM, Fabian C, Lee SE, Rhee JH, Cho KA. Flagellin-dependent TLR5/caveolin-1 as a promising immune activator in immunosenescence. Aging Cell. 2015;14(5):907–15. doi:10.1111/acel.12383. PMID:26223660
   PubMed Web of Science ®Google Scholar
• Frazer LT, O'Brien-Simpson NM, Slakeski N, Walsh KA, Veith PD, Chen CG, Barr IG, Reynolds EC. Vaccination with recombinant adhesins from the RgpA-Kgp proteinase-adhesin complex protects against Porphyromonas gingivalis infection. Vaccine. 2006;24:6542–54. doi:10.1016/j.vaccine.2006.06.013. PMID:16839648
   PubMed Web of Science ®Google Scholar
• Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiol Lett. 2012;333:1–9. doi:10.1111/j.1574-6968.2012.02579.x. PMID:22530835
   PubMed Web of Science ®Google Scholar
• Curtis MA, Kuramitsu HK, Lantz M, Macrina FL, Nakayama K, Potempa J, Reynolds EC, Aduse-Opoku J. Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis. J Periodontal Res. 1999;34:464–72. doi:10.1111/j.1600-0765.1999.tb02282.x. PMID:10697803
   PubMed Web of Science ®Google Scholar
• Nakayama K. Porphyromonas gingivalis cell-induced hemagglutination and platelet aggregation. Periodontol 2000. 2010;54:45–52. doi:10.1111/j.1600-0757.2010.00351.x. PMID:20712632
   PubMed Web of Science ®Google Scholar
• Muramatsu K, Kokubu E, Shibahara T, Okuda K, Ishihara K. HGP44 induces protection against Porphyromonas gingivalis-Induced alveolar bone loss in mice. Clin Vaccine Immunol. 2011;18:888–91. doi:10.1128/CVI.00556-10. PMID:21430125
   PubMed Web of Science ®Google Scholar
• Gibson FC, 3rd, Genco CA. Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Infect Immun. 2001;69:7959–63. doi:10.1128/IAI.69.12.7959-7963.2001. PMID:11705986
   PubMed Web of Science ®Google Scholar
• Miyachi K, Ishihara K, Kimizuka R, Okuda K. Arg-gingipain A DNA vaccine prevents alveolar bone loss in mice. J Dent Res. 2007;86:446–50. doi:10.1177/154405910708600511. PMID:17452566
   PubMed Web of Science ®Google Scholar
• O'Brien-Simpson NM, Pathirana RD, Paolini RA, Chen YY, Veith PD, Tam V, Ally N, Pike RN, Reynolds EC. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J Immunol. 2005;175:3980–9. doi:10.4049/jimmunol.175.6.3980. PMID:16148146
   PubMed Web of Science ®Google Scholar
• Sakai E, Naito M, Sato K, Hotokezaka H, Kadowaki T, Kamaguchi A, Yamamoto K, Okamoto K, Nakayama K. Construction of recombinant hemagglutinin derived from the gingipain-encoding gene of Porphyromonas gingivalis, identification of its target protein on erythrocytes, and inhibition of hemagglutination by an interdomain regional peptide. J Bacteriol. 2007;189:3977–86. doi:10.1128/JB.01691-06. PMID:17384191
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Baba A, Abe N, Takii R, Hashimoto M, Tsukuba T, Okazaki S, Suda Y, Asao T, Yamamoto K. Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors. Mol Pharmacol. 2004;66:1599–606. doi:10.1124/mol.104.004366. PMID:15361547
   PubMed Web of Science ®Google Scholar
• Tagawa H, Kiyama-Kishikawa M, Lee SY, Abiko Y. Inhibition of hemagglutinating activity by monoclonal antibody against Porphyromonas gingivalis 40-kDa outer membrane protein. Hybrid Hybridomics. 2004;23:183–6. doi:10.1089/1536859041224244. PMID:15312309
   PubMedGoogle Scholar
• Momoi F, Hashizume T, Kurita-Ochiai T, Yuki Y, Kiyono H, Yamamoto M. Nasal vaccination with the 40-kgdalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies. Infect Immun. 2008;76:2777–84. doi:10.1128/IAI.01502-07. PMID:18411288
   PubMed Web of Science ®Google Scholar
• Lee YT, Kim KH, Ko EJ, Lee YN, Kim MC, Kwon YM, Tang Y, Cho MK, Lee YJ, Kang SM. New vaccines against influenza virus. Clin Exp Vaccine Res. 2014;3:12–28. doi:10.7774/cevr.2014.3.1.12. PMID:24427759
   PubMedGoogle Scholar
• Pabst R. Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)-Structure, function and species differences. Vaccine. 2015;33:4406–13.
   PubMed Web of Science ®Google Scholar
• Nagai Y, Shiraishi D, Tanaka Y, Nagasawa Y, Ohwada S, Shimauchi H, Aso H, Endo Y, Sugawara S. Transportation of sublingual antigens across sublingual ductal epithelial cells to the ductal antigen-presenting cells in mice. Clin Exp Allergy. 2015;45:677–86. doi:10.1111/cea.12329. PMID:24773115
   PubMed Web of Science ®Google Scholar
• Kraan H, Vrieling H, Czerkinsky C, Jiskoot W, Kersten G, Amorij JP. Buccal and sublingual vaccine delivery. J Control Release. 2014;190:580–92. doi:10.1016/j.jconrel.2014.05.060. PMID:24911355
   PubMed Web of Science ®Google Scholar
• Foged C. Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Ther Deliv. 2011;2:1057–77. doi:10.4155/tde.11.68. PMID:22826868
   PubMedGoogle Scholar
• Moyle PM, Toth I. Modern subunit vaccines: development, components, and research opportunities. ChemMedChem. 2013;8:360–76. doi:10.1002/cmdc.201200487. PMID:23316023
   PubMed Web of Science ®Google Scholar
• Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19:1597–608. doi:10.1038/nm.3409. PMID:24309663
   PubMed Web of Science ®Google Scholar
• Choi EK, Kim SY, Kim SH, Paek YW, Kang IC. Proteolytic activity of Porphyromonas gingivalis attenuates MCP-1 mRNA expression in LPS-stimulated THP-1 cells. Microb Pathog. 2014;73:13–8. doi:10.1016/j.micpath.2014.05.004. PMID:24875922
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Briles DE, Yamamoto S, Ohmura M, Kiyono H, McGhee JR. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A. J Immunol. 1998;161:4115–21; PMID: 9780183.
   PubMed Web of Science ®Google Scholar
• Xu XC, Chen H, Zhang X, Zhai ZJ, Liu XQ, Qin A, Lu EY. Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomy. J Transl Med. 2014;12:284. doi:10.1186/s12967-014-0284-0. PMID:25269614
   PubMed Web of Science ®Google Scholar
• Liu YF, Wu LA, Wang J, Wen LY, Wang XJ. Micro-computerized tomography analysis of alveolar bone loss in ligature- and nicotine-induced experimental periodontitis in rats. J Periodontal Res. 2010;45:714–9. doi:10.1111/j.1600-0765.2010.01290.x. PMID:20572916
   PubMed Web of Science ®Google Scholar
• Jeong BC, Choi H, Hur SW, Kim JW, Oh SH, Kim HS, Song SC, Lee KB, Park KB, Koh JT. Repair of Cranial Bone Defects Using rhBMP2 and Submicron Particle of Biphasic Calcium Phosphate Ceramics with Through-Hole. Biomed Res Int. 2015;2015:926291. doi:10.1155/2015/926291. PMID:26491693
   PubMed Web of Science ®Google Scholar